Cytokines: abnormalities in major depression and implications for pharmacological treatment.
AffiliationDepartment of Psychiatry, University College Cork, Cork University Hospital,, Wilton Road, Cork, Ireland.
MeSHAntidepressive Agents/*therapeutic use
Depressive Disorder, Major/*drug therapy/immunology/*metabolism
MetadataShow full item record
CitationHum Psychopharmacol. 2004 Aug;19(6):397-403.
AbstractThe role of cytokines in depression was first considered when the cytokine interferon resulted in "sickness behaviour", the symptoms of which are similar to those of major depression. The latter is associated with an increase in pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha). These cytokines are potent modulators of corticotropin-releasing hormone (CRH) which produces heightened hypothalamic-pituitary-adrenal axis (HPA) activity characterized by increases in ACTH and cortisol, both of which are reported elevated in major depression. Antidepressant treatment has immunomodulatory effects with increases in the production of IL-10, which is an anti-inflammatory cytokine. This review based on a Medline search from 1980-2003, focuses on the evidence available of cytokine changes in acute stress, chronic stress and major depression. It examines the effects of antidepressant treatment on immune parameters in both animal models and clinical trials. We suggest that future antidepressants may target the immune system by either blocking the actions of pro-inflammatory cytokines or increasing the production of anti-inflammatory cytokines.
- Cytokines and major depression.
- Authors: Schiepers OJ, Wichers MC, Maes M
- Issue date: 2005 Feb
- [Antidepressants and cytokines--clinical and experimental studies].
- Authors: Obuchowicz E, Marcinowska A, Herman ZS
- Issue date: 2005 Sep-Oct
- The immune system, depression and the action of antidepressants.
- Authors: Leonard BE
- Issue date: 2001 May
- Changes in the immune system in depression and dementia: causal or co-incidental effects?
- Authors: Leonard BE
- Issue date: 2001 Jun
- Vasopressin as a target for antidepressant development: an assessment of the available evidence.
- Authors: Scott LV, Dinan TG
- Issue date: 2002 Nov